Q3 2024 · 13F-HR
First Light Asset Management, LLCholdings as filed
Filed 2024-11-14 · accession 0001839882-24-039271
$1.20B
Reported value
38
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS LIMITED | $95.0M | 7.90% | 5,940,132 | Common | SOLE |
| 69913P105 | FNAUSD | PARAGON 28 INC | $67.8M | 5.64% | 10,154,643 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $65.0M | 5.41% | 2,298,261 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $57.3M | 4.77% | 4,090,296 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $52.3M | 4.35% | 1,865,536 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $50.3M | 4.18% | 688,910 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS INC | $48.2M | 4.01% | 943,611 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS | $46.5M | 3.87% | 1,181,662 | Common | SOLE |
| 64049M209 | NEO | NEOGENOMICS INC | $45.4M | 3.78% | 3,076,555 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $45.2M | 3.76% | 1,257,285 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $43.5M | 3.62% | 1,025,307 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL INC | $41.9M | 3.49% | 755,102 | Common | SOLE |
| 71377E105 | PFMTUSD | PERFORMANT FINANCIAL CORPORATION | $41.9M | 3.49% | 11,210,400 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $41.7M | 3.47% | 265,734 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC CLASS A | $37.5M | 3.12% | 1,765,892 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $37.0M | 3.08% | 159,082 | Common | SOLE |
| 42225T107 | HCAT | HEALTH CATALYST INC | $35.0M | 2.91% | 4,296,490 | Common | SOLE |
| 032724106 | ANAB | ANAPTYS BIO INC | $31.8M | 2.64% | 948,131 | Common | SOLE |
| 05368M106 | PPHMEUR | AVID BIOSERVICES INC | $31.5M | 2.62% | 2,771,853 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $31.2M | 2.59% | 705,234 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $28.9M | 2.40% | 2,575,546 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $24.7M | 2.05% | 165,873 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $23.5M | 1.95% | 184,939 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $22.2M | 1.85% | 506,222 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $21.9M | 1.82% | 967,006 | Common | SOLE |
| 825704109 | SIBN | SI-BONE INC | $21.3M | 1.78% | 1,526,215 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $19.2M | 1.60% | 406,348 | Common | SOLE |
| 759910102 | KRMD | KORU MEDICAL SYSTEMS INC | $15.3M | 1.27% | 5,598,925 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH | $14.9M | 1.24% | 648,993 | Common | SOLE |
| 68401U204 | OPRX | OPTIMIZERX CORP | $14.0M | 1.16% | 1,811,611 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $10.9M | 0.91% | 1,542,406 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $9.3M | 0.77% | 359,150 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $9.1M | 0.76% | 26,528 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $7.7M | 0.64% | 51,723 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MEDICAL INC. | $7.2M | 0.60% | 174,590 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $4.7M | 0.39% | 69,447 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HOLDINGS INC | $767,313 | 0.06% | 138,006 | Common | SOLE |
| 835431107 | — | SONENDO INC | $253,696 | 0.02% | 5,886,207 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.